Some retina specialists aim to dry retinas completely when treating wet AMD, while others tolerate fluid. How can they turn to data to make evidence-based decisions about which approach works best? Using a real-world patient case as a backdrop, Justis P. Ehlers, MD, FASRS, and Michael Ip, MD, dive into the great fluid debates by defining fluid subtypes, reviewing data that make observers question whether all fluid is linked to reduced quality of vision, and assessing the value of structural stability in eyes with fluid fluctuations.
Anatomic and Visual Outcomes in Retinal Vascular Diseases: The Fluid Challenge
Media formats available:
Details
Presenters
Commercial Support
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Assess the correlation between anatomic measures of disease activity and visual outcomes in retinal vascular diseases
- Appraise anatomic and visual outcomes gained from second-generation treatments for retinal vascular diseases
- Implement an evidence-based approach to individualize treatment for patients with retinal vascular diseases
Accreditation
Provided by Evolve Medical Education
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Participation Method
In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.
Faculty and Disclosures
Justis P. Ehlers, MD, FASRS
Cole Eye Institute
Cleveland, OH
Michael Ip, MD
University of California - Los Angeles
Pasadena, CADISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.The following faculty/staff members have the following financial relationships with commercial interests:
Justis P. Ehlers, MD, FASRS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Adverum Biotechnologies, Alcon, Alexion, Allegro Ophthalmics, Allergan, Apellis Pharmaceuticals, Bayer, Beyeonics, Boehringer Ingelheim, BVI, Carl Zeiss Meditec, Exegenesis, EyePoint Pharmaceuticals, Genentech, Iveric Bio, Leica/Bioptigen, Novartis, Ophthalytics, Perceive Bio, Regeneron, Regenxbio, Roche, and Stealth BioTherapeutics. Grant/Research Support: Adverum Biotechnologies, Aerpio, Alcon, Alexion, Allergan, Beyeonics, Boehringer Ingelheim, Carl Zeiss Meditec, Genentech, Iveric Bio, Novartis, Oxurion, Perceive Bio, Regeneron, Roche, and Stealth BioTherapeutics.
Michael Ip, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consulting: Adverum Biotechnologies, Alimera, Allergan, Amgen, Apellis, Astellas, Clearside Biomedical, Genentech, Novartis, Regeneron, and Regenxbio. Grant/Research Support: Adverum Biotechnologies, Apellis, Astellas, Biogen, Genentech, Lineage Cell Therapeutics, ONL Therapeutics, Regeneron, Regenxbio, Splice Bio, and 4DMT.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron.This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
John W. Kitchens, MD
Sara LeMay, OD
Sunir J. Garg, MD, FACS, FASRS
Charles C. Wykoff, MD, PhD, FACS
Sunir J. Garg, MD, FACS, FASRS
Charles C. Wykoff, MD, PhD, FACS
Elizabeth (Beth) Richter, MD, PhD
Julie Rodman, OD, MSc
